MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    40,000 Instrumented Timed-up-and-go Tests – Standardization is within Reach

    Z. Yekutieli, P. Lewitt (Tel Aviv, Israel)

    Objective: Timed-up-and-go (TUG) is a standard test in neurological assessment. TUG completion time is currently the only quantitative result reported and matched against age and…
  • 2025 International Congress

    Diagnostic accuracy of CSF tap test parameters in Normal pressure hydrocephalus: An ambispective cohort study

    A. Elavarasi, S. Poudel, M. Tripathi, N. Wig, A. Srivastava, S. Kale, A. Suri, S. P, A. Garg, R. Rajan, D. Radhakrishnan, R. Singh (New Delhi, India)

    Objective: To study the sensitivity and specificity of CSF tap test in predicting outcomes following shunt surgery Background: Idiopathic Normal pressure hydrocephalus (iNPH) is a…
  • 2025 International Congress

    When post-radiotherapy parkinsonism can hide another one : A case report.

    S. Puisieux, S. Chouinard, A. Veilleux-Carpentier (Montreal, Canada)

    Objective: To describe a patient who presented with subacute and reversible post-radiotherapy parkinsonism (<2 months), allowing treatments to be weaned; and then delayed post-radiotherapy parkinsonism…
  • 2025 International Congress

    Efficacy of Stimulant Use for Cognitive Fluctuations in Lewy Body Dementia: A Case Study

    L. Lopez, A. Petrov, Z. Afshari (Glenview, USA)

    Objective: To evaluate the effectiveness of stimulants in reducing cognitive fluctuations in Lewy Body Dementia (LBD). Background: Lewy Body Dementia (LBD) is the 2nd most…
  • 2025 International Congress

    Expanding the Geographic Spectrum of Guam Complex: A Case Report from Colombia

    A. Alonso, L. Granados, A. Ferreiros (Bogotá, Colombia)

    Objective: To describe the case of a patient presenting with a progressive neurodegenerative syndrome characterized by the coexistence of dementia, parkinsonism, and motor neuron disease.…
  • 2025 International Congress

    Concomitant Progressive Supranuclear Palsy and Amyotrophic Lateral Sclerosis Versus Motoneuron Phenotype of PSP in Ukrainian Patient

    Y. Trufanov, Y. Compta, M. Trishchynska, N. Khanenko, G. Chupryna, V. Sereda, A. Ovchynnykova (Kyiv, Ukraine)

    Objective: To provide a description of a rare case of mixed progressive supranuclear palsy (PSP) and amyotrophic lateral sclerosis (ALS) in Ukrainian patient. Background: The…
  • 2025 International Congress

    Proteome-Wide Association Study Identifies Plasma β-Glucuronidase as a Causal Risk Protein for Multiple System Atrophy

    X. Chen, X. Wang, B. Wang, W. Luo (Hangzhou, China)

    Objective: This study aims to identify plasma proteins associated with multiple system atrophy (MSA), using a proteome-wide association study (PWAS) and to determine their causal roles…
  • 2025 International Congress

    Atrophy In Multiple System Atrophy Relates To Mitochondrial And Oligodendrocytic Processes

    L. Chougar, C. Tremblay, A. Delva, M. Filiatraul, A. Vo, J. Hansen, A. Farahani, B. Misic, P. Khalafi, CE. Castonguay, G. Rouleau, JC. Corvol, M. Vidailhet, B. Degos, D. Grabli, S. Lehéricy, A. Dagher, S. Rahayel (Montreal, Canada)

    Objective: To investigate the gene expression and neurobiological underpinnings of brain atrophy in MSA using imaging transcriptomics and PET-based molecular annotation Background: The biological mechanisms…
  • 2025 International Congress

    Metabolic Patterns in Multiple System Atrophy: Brain Network Insights from Spatial ICA of FDG-PET

    J. Li, H. Wang, B. Wang, Z. Cen, W. Luo (Hangzhou, China)

    Objective: This study employs spatial independent component analysis (ICA) on 18F-fluorodeoxyglucose (FDG)-PET imaging to decompose metabolic heterogeneity in Multiple system atrophy (MSA), identifying key brain…
  • 2025 International Congress

    Spatial Metabolic Covariance Networks in PSP: Implications for Symptomatology and their Neural Basis

    B. Wang, W. Luo (Hangzhou, China)

    Objective: This study aimed to apply spatial ICA to 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) data from PSP patients and healthy controls (HCs) to identify…
  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley